# Aligos Therapeutics, Inc.: Form 8-K, filed Oct 25, 2023

- Company: [Aligos Therapeutics, Inc.](/companies/algs.md) (CIK 1799448)
- Form: 8-K
- Filed: 2023-10-25
- Accepted by EDGAR: Oct 25, 2023, 17:05 ET
- Period: 2023-10-23
- Accession: 0001193125-23-263158
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1799448/000119312523263158/d533607d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799448/000119312523263158/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799448/000119312523263158/d533607d8k.htm

Filed Oct 25, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-263158. Last ingested by Listed: Nov 6, 2026, 12:13 ET. No prices; not investment advice.